TSMHT
IBB icon

Thurston Springer Miller Herd & Titak’s iShares Biotechnology ETF IBB Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-144
Closed -$18.3K – 925
2025
Q2 		$18.3K Hold
144
– – ﹤0.01% 975
2025
Q1 		$18.5K Buy
+144
New +$19.5K ﹤0.01% 905

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's IBB Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 144 shares — an estimated $18.3K sold.

Thurston Springer Miller Herd & Titak first reported a position in IBB in Q1 2025 and held it in 2 quarters. The position peaked at $18.5K in Q1 2025. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 144 iShares Biotechnology ETF shares in Q3 2025, an estimated $18.3K.
  • Thurston Springer Miller Herd & Titak first reported a position in iShares Biotechnology ETF in Q1 2025 and held it in 2 quarters.
  • Thurston Springer Miller Herd & Titak's iShares Biotechnology ETF position peaked at $18.5K in Q1 2025.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.